FMP
Armata Pharmaceuticals, Inc.
ARMP
AMEX
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has a partnership agreement with Merck & Co. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.
2.24 USD
0.18 (8.04%)
Date
Open
Low
High
Close
Volume
Change
Change %
2025-01-21 09:34:00
2.04
2.04
2.12
2.04
2.44k
-
-
2025-01-21 09:35:00
2.04
2.04
2.04
2.04
0
0
0
2025-01-21 09:36:00
2.23
2.21
2.23
2.21
1.93k
0.18
8.58
2025-01-21 09:37:00
2.23
2.14
2.24
2.24
2.61k
0.02
0.97
2025-01-21 09:38:00
2.09
2.09
2.09
2.09
200
-0.15
-6.55
2025-01-21 09:39:00
2.05
2.04
2.12
2.12
2.6k
0.03
1.44
2025-01-21 10:00:00
2.12
2.12
2.13
2.13
1.5k
0.01
0.47
2025-01-21 10:16:00
2.13
2.13
2.13
2.13
180
0
0.23
2025-01-21 10:17:00
2.13
2.13
2.13
2.13
0
0
0
2025-01-21 12:02:00
2.2
2.16
2.2
2.16
1.62k
0.03
1.17
2025-01-21 12:42:00
2.17
2.17
2.17
2.17
100
0.01
0.69
2025-01-21 12:59:00
2.16
2.16
2.16
2.16
100
-0.01
-0.69
2025-01-21 13:00:00
2.16
2.16
2.16
2.16
0
0
0
2025-01-21 14:08:00
2.18
2.18
2.18
2.18
356
0.02
0.93
2025-01-21 14:09:00
2.18
2.18
2.18
2.18
0
0
0
2025-01-21 15:13:00
2.21
2.18
2.21
2.19
2.98k
0
0.23
2025-01-21 15:14:00
2.21
2.18
2.21
2.19
2.98k
0
0
2025-01-21 15:15:00
2.24
2.24
2.24
2.24
100
0.06
2.52
2025-01-21 15:46:00
2.19
2.19
2.24
2.24
2.82k
-0
-0
2025-01-21 15:47:00
2.24
2.24
2.24
2.24
500
0
0
2025-01-21 15:59:00
2.24
2.24
2.24
2.24
500
0
0